Protein C Inhibitor and Serum Amyloid A in Immune Thrombocytopaenic Purpura

Author： Sayinalp N   Haznedaroğlu IC   Büyükaşik Y   Göker H   Aksu S   Koçoğlu H   Özcebe OI   Koşar A   Kirazli Ş   Dündar SV  

Publisher： Field House Publishing

ISSN： 0300-0605

Source： The Journal of International Medical Research, Vol.32, Iss.1, 2004-01, pp. : 62-65

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Suspected hydroxychloroquine‐induced thrombotic thrombocytopaenic purpura

By  

JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol. 48, Iss. 1, 2018-02 ,pp. : 72-75

John Wiley & Sons Inc

Access to resources Recommend Favorite

Rituximab: Serum sickness in a child with immune thrombocytopenic purpura: case report

By  

Reactions Weekly, Vol. 1, Iss. 1272, 2009-01 ,pp. : 28-28

Adis International

Access to resources Recommend Favorite

R 788 [tamatinib fosdium], a syk kinase inhibitor, potentially improves platelet counts in patients with chronic immune thrombocytopenia purpura

By  

Inpharma, Vol. 1, Iss. 1615, 2007-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

Amyloid Precursor Protein Expression Modulates Intestine Immune Phenotype

By Puig Kendra  

Journal of Neuroimmune Pharmacology, Vol. 7, Iss. 1, 2012-03 ,pp. : 215-230

Springer Publishing Company

Access to resources Recommend Favorite

Dexamethasone effective in immune thrombocytopenic purpura

By  

Inpharma, Vol. 1, Iss. 1403, 2003-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite